| After Biologic COVID-19 Drug OK’d in India, Equillium Plans a US Test | Sarah de Crescenzo | 07/14/20 | San Diego |
| Fauci Foresees “More Than 1 Winner” in Race for COVID-19 Vaccines, Drugs | Sarah de Crescenzo | 06/10/20 | National |
| BARDA Director Rick Bright Moves to NIH to Head COVID-19 Testing R&D | Sarah de Crescenzo | 04/21/20 | National |
| Bio Roundup: Coronavirus Diagnostics, Therapeutics, Vaccines & More | Sarah de Crescenzo | 03/20/20 | National |
| Court Rules More Trial Data Must Be Posted On ClinicalTrials.gov | Brenda Sandburg | 03/04/20 | National |
| Gilead, Moderna Candidates Ramp Up Coronavirus Drug, Vaccine Testing | Sarah de Crescenzo | 02/27/20 | National |
| WI Watchlist: Epic, Frontdesk, Shine, StartingBlock Madison & More | Jeff Bauter Engel | 09/06/19 | Wisconsin |
| Bio Roundup: ASCO Wrap, Bluebird’s EU Tap, CRISPR Baby Risk & More | Alex Lash | 06/07/19 | National |
| Tasso Gets $6M For Device That Lets Users Self-Collect Blood Samples | Jeff Buchanan | 03/05/19 | Seattle |
| Packers, Cool Products, Cellectar & More: This Week’s WI Watchlist | Jeff Buchanan | 09/20/18 | Wisconsin |
| NIH Using Vaccines from Madison Startup FluGen in New Clinical Trial | Jeff Buchanan | 09/19/18 | Wisconsin |
| Some of the Best Reads for Casual Friday: Artificial Intelligence | David Holley | 06/22/18 | National |
| NIH Outlines $500M Plan to Develop New Pain Drugs and Fight Opioid Crisis | Corie Lok | 06/13/18 | National |
| FluGen to Study Versatility of Its Universal Flu Vaccine Candidate | Jeff Buchanan | 05/17/18 | Wisconsin |
| The Revolution in Inflammation Drug Development | Gary Glick | 05/15/18 | Boston |
| FluGen May Seek Funding from $12M Gates-Backed Flu Vaccine Challenge | Jeff Buchanan | 05/01/18 | Wisconsin |
| Bio Roundup: Trump’s Budget, Biogen’s AD Reveal, Hugin’s Run & More | Alex Lash | 02/16/18 | National |
| Bio Roundup: Spark’s Road Ahead, Juno Rumors, Merck’s Big Day & More | Ben Fidler | 01/19/18 | National |
| Few Opioid Alternatives In Sight as Crisis Gains Political Attention | Corie Lok | 11/01/17 | National |
| Bio Roundup: CBO’s Praise, Celgene’s Shock, Trump’s Opioid Plan & More | Alex Lash | 10/27/17 | National |
| Fresh Off New Funding Round, FluGen Plans 3 Clinical Trials for 2018 | Jeff Buchanan | 08/04/17 | Wisconsin |
| Bio Roundup: Obamacare Persists, FDA Approves, Vertex Wows & More | Alex Lash | 07/21/17 | National |
| Exact, Microscopy, FairSquare, & More: This Week’s WI Watchlist | Jeff Buchanan | 07/12/17 | Wisconsin |
| Bio Roundup: Skinny Cuts, Genomic Approvals, Unfrozen FDA & More | Alex Lash | 05/26/17 | National |
| Amid Budget Concerns, NIH Preps Beta Test for Precision Medicine Plan | Frank Vinluan | 05/25/17 | National |
| Bio Roundup: Big Apple Mo’, Checkpoint Yes and No, CAR-T Death & More | Alex Lash | 05/12/17 | National |
| Emulate’s “Organ-on-a-Chip” Tech Picked for FDA Research Partnership | Frank Vinluan | 04/11/17 | Boston |
| Bio Roundup: New Drug Bonanza, Vertex’s Triple Play, CAR-T Race & More | Ben Fidler | 03/31/17 | National |
| Arrowhead, Research Cuts, JCI, & More: This Week’s WI Watchlist | Jeff Buchanan | 03/24/17 | Wisconsin |
| Lynx Bio Makes Headway on New Diagnostic for Blood Cancer Drugs | Jeff Buchanan | 02/13/17 | Wisconsin |
